Routine senior management appointment with no financial disclosures. Monitor for any future strategic shifts in the API and Services segment under new leadership.
Price Chart
Executive Summary
Dr. Reddy's Laboratories appointed Mr. Akhil Ravi as Head API and Services and Senior Management Personnel, effective November 13, 2026. Mr. Ravi, who is the son-in-law of Co-Chairman and Managing Director G.V. Prasad, will continue overseeing Aurigene Pharmaceutical Services Ltd. This is a routine senior management appointment with no material financial impact.
Key Facts
- Mr. Akhil Ravi appointed as Head API and Services and Senior Management Personnel, effective November 13, 2026
- Mr. Ravi is a related party, being the son-in-law of Co-Chairman and Managing Director G.V. Prasad
- Mr. Ravi will continue as CEO of Aurigene Pharmaceutical Services Ltd., a wholly owned subsidiary
- Board meeting held October 23, 2026, from 3:00 p.m. to 4:38 p.m. IST
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000724 |
| Document: 0001575872-26-000724-index.html | 0001575872-26-000724 |
| Document: 0001575872-26-000724.txt | 0001575872-26-000724 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 2d ago | 6-K | $13.75 | awaiting T+5 | awaiting T+5 | $14.17 (+3.05%) |
Oct 26, 2026 2d ago | 6-K | $13.75 | awaiting T+5 | awaiting T+5 | $14.17 (+3.05%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.17 (−7.27%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.17 (+7.27%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.17 (+7.27%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.17 (−7.27%) |
Oct 21, 2026 7d ago | 6-K | $13.19 | awaiting T+5 | awaiting T+5 | $14.17 (+7.43%) |
Oct 14, 2026 13d ago | 6-K | $12.75 $13.19 | ▲ +3.45% | ▲ +3.00% | $14.17 (+11.14%) |
Oct 8, 2026 20d ago | 6-K | $12.20 $12.90 | ▲ +5.74% | ▲ +6.01% | $14.17 (+16.15%) |
Oct 7, 2026 21d ago | 6-K | $12.27 $12.75 | ▲ +3.91% | ▲ +4.89% | $14.17 (+15.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers